Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 266-268

  Pandey, Rajesh ^a   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bioavailability; Poly (DL lactide co glycolide); Tuberculosis

Indexed keywords

ISONIAZID; NANOPARTICLE; POLYGLACTIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; EMULSION; ENCAPSULATION; EXPERIMENTAL MODEL; LUNG PARENCHYMA; MEAN RESIDENCE TIME; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SINGLE DRUG DOSE; SPLEEN; SUSTAINED DRUG RELEASE; TUBERCULOSIS;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BIOLOGICAL AVAILABILITY; DRUG COMBINATIONS; DRUG COMPOUNDING; INJECTIONS, SUBCUTANEOUS; ISONIAZID; LACTIC ACID; LUNG; MICE; MICROSPHERES; MYCOBACTERIUM TUBERCULOSIS; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; PYRAZINAMIDE; RIFAMPIN; SPLEEN; TISSUE DISTRIBUTION; TUBERCULOSIS;

EID: 3543139595     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh260     Document Type: Article

References (7)

1. Fauci, A. S. (2001). Infectious diseases: considerations for the 21st century. Clinical Infectious Diseases 32, 675-85.
2. Pandey, R., Zahoor, A., Sharma, S. et al. (2003). Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against experimental murine tuberculosis. Tuberculosis (Edinburgh, Scotland) 83, 373-8.
3. Pandey, R., Sharma, A., Zahoor, A. et al. (2003). Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. Journal of Antimicrobial Chemotherapy 52, 981-6.
4. Lamprecht, A., Ulbrich, N., Hombreiro, P. M. et al. (1999). Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. International Journal of Pharmaceutics 184, 97-105.
5. Jain, R., Shah, N. H., Malick, A. W. et al. (1998). Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Development and Industrial Pharmacy 24, 703-27.
6. Dutt, M. & Khuller, G. K. (2001). Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles. Journal of Antimicrobial Chemotherapy 47, 829-35.
7. Dutt, M. & Khuller, G. K. (2001). Therapeutic efficacy of poly (DL-lactide-co-glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice. Antimicrobial Agents and Chemotherapy 45, 363-6.